Eiger BioPharmaceuticals, Inc. (EIGRQ)

Eiger BioPharmaceuticals Market Cap

Eiger BioPharmaceuticals is not actively traded anymore. When Eiger BioPharmaceuticals last traded, it had a market cap or net worth of $12.59 million.

• Market Cap: 12.59M
• Enterprise Value: -19.14M
• Revenue: 15.77M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: $8.50

Market Cap Chart

Range1 Month6 MonthsYear to Date1 Year3 Years5 Years

Since March 23, 2016, Eiger BioPharmaceuticals's market cap has decreased from 111.23M to 12.59M, a decrease of -88.68%. That is a compound annual growth rate of -22.57%.

Market Cap History

Date	Market Cap	% Change
Sep 27, 2024	12.59M	26.32%
Dec 29, 2023	9.96M	-80.84%
Dec 30, 2022	52.01M	-70.51%
Dec 31, 2021	176.33M	-55.90%
Dec 31, 2020	399.81M	9.55%